首頁 > 市場調查報告書 > 醫療設備

病患監測呼吸器

市場調查報告書

商品編碼

1345406

全球呼吸迴路市場 - 2023-2030

Global Breathing Circuits Market - 2023-2030

出版日期: 2023年09月06日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球呼吸迴路市場將於 2022 年達到 12 億美元，預計到 2030 年將達到 17 億美元，2023-2030 年預測期間年複合成長率為 4.4%。

呼吸迴路的理想特性包括氣流阻力低、先前呼出氣體的再呼吸最少、以二氧化碳產生的速度去除二氧化碳、需要時輸送氣體成分的快速變化、吸入氣體的加溫加濕，並安全處置廢氣。

呼吸迴路的發展歷史與麻醉劑和技術的進步並行。現代呼吸迴路可以根據二氧化碳吸收、閥門位置和稀釋新鮮氣體的使用等特徵進行分類。呼吸迴路的組件包括管道、閥門、儲液袋、連接器和輸送組件，例如現代體積反射器。

此外，全球呼吸循環是由多種因素驅動的，例如由於有利的監管環境和不斷增加的患有慢性疾病的人口，一些主要參與者正在全球範圍內擴大其製造設施。呼吸功能障礙發病率的上升也將推動對呼吸迴路的需求。

動力學

呼吸道疾病患病率上升

呼吸道疾病患病率的增加是預測期內幫助市場成長的關鍵促進因素之一。由於呼吸系統疾病的增加，根據疾病範圍需要通氣，確實需要使用呼吸迴路，這確實會增加市場的成長。

例如，根據疾病控制和預防中心的數據，慢性阻塞性肺病估計影響 2000 億人，每年有 32 億人死亡，使其成為全球第三大死亡原因。

哮喘是最常見的非傳染性疾病之一，影響著全球 2620 億人。預計到 2022 年，肺癌新增病例將達到近 22 億，死亡人數將達到 18 億，肺癌佔全球癌症死亡人數的四分之一。下呼吸道感染或肺炎是一個重要的死亡原因，每年造成超過 24 億人死亡，主要發生在低收入和中等收入國家 (LMIC)。 COVID-19 顯著增加了全球肺炎死亡人數。

呼吸迴路的技術進步

呼吸迴路的技術進步是預測期內幫助市場成長的關鍵因素之一。最近麻醉護理方面取得了一些進展，例如直接注射揮發性麻醉劑、麻醉劑保存裝置、紅外低成本分析儀和閉路麻醉。

閉路系統已成為麻醉輸送系統的最新改進。這些系統通過匹配患者的氧氣和麻醉劑消耗來發揮作用，這與之前具有恆定低新鮮氣體流量和廢氣清除系統的方法不同。

阻塞性睡眠呼吸暫停患病率上升

阻塞性睡眠呼吸暫停患病率的上升是預測期內市場加速成長的驅動力。例如，根據美國睡眠呼吸暫停協會的數據，僅 180 億美國人就患有睡眠呼吸暫停。該統計數據表明，大約每 15 個美國人中就有 1 人（即美國總人口的 6.62%）患有睡眠呼吸暫停。加州大學聖地亞哥分校進行的一項研究對 54 名非裔美國人和 346 名白人進行了睡眠呼吸暫停的研究。

結果顯示，17% 的非裔美國人受試者患有阻塞性睡眠呼吸暫停，而白人受試者中這一比例為 8%。這表明非裔美國人患阻塞性睡眠呼吸暫停的風險增加的假設。百分之二到百分之四的美國人患有未確診的睡眠呼吸暫停病例。這約佔每 50 人中就有 1 人未被確診。

增加 ICU 呼吸迴路的需求

ICU 呼吸迴路需求的增加是預測期內幫助市場成長的關鍵因素之一。重症監護病房使用呼吸迴路來幫助患者進行呼吸過程。這些電路連接到機械呼吸機，用於向患者提供氧氣並去除二氧化碳。呼吸迴路的目的是為患者提供可控且安全的氣流，同時通過在呼出的空氣或水分到達呼吸機之前收集其來防止感染。因此，呼吸迴路可以將富氧空氣輸送到患者的肺部，同時去除二氧化碳。

產品召回

產品召回是預測期內阻礙市場成長的因素之一。例如，2023 年 5 月，Draeger Medical 發現由於製造錯誤，粘合連接可能在通氣前或通氣過程中鬆動，因此召回了 Seattle PAP Plus 以及 VentStar 和其他呼吸迴路/麻醉套件。結果可能會導致包括聚水器、Y 形接頭或軟管連接器在內的組件部分或完全脫離。

這些部件鬆動或脫落可能會中斷呼吸迴路，並可能導致嚴重傷害，包括缺氧（缺氧）或死亡。對於包括新生兒（新生兒）在內的重症患者來說，受傷或死亡的風險尤其大。因此，上述因素將限制市場在預測期內的成長。

此外，雖然呼吸迴路在醫院、診所、門診手術中心和家庭護理機構中的使用不斷擴大，但預計有幾個問題將限制全球市場的擴張。由於單向閥和二氧化碳吸收增加，患者可能會出現呼吸困難。

Overview

Global Breathing Circuits Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 1.7 billion by 2030, growing with a CAGR of 4.4% during the forecast period 2023-2030.

The desirable characteristics of a breathing circuit include low resistance to gas flow, minimal rebreathing of the preceding exhaled gases, removal of carbon dioxide at the rate at which it is produced, rapid changes in delivered gas composition when required, warmed humidification of the inspired gases, and safe disposal of waste gases.

The history of the development of breathing circuits parallels advancements in anaesthetic agents and techniques. Modern breathing circuits can be classified according to characteristics such as carbon dioxide absorption, valve position, and the use of diluting fresh gases. The components of the breathing circuit include the tubing, valves, reservoir bag, connectors, and delivery assemblies such as the modern volume reflector.

Furthermore, the global breathing circuit is driven by various factors, like several key players are expanding their manufacturing facilities across the globe owing to a favourable regulatory environment and an ever, increasing population suffering from chronic ailments. The rising incidence of respiratory dysfunctions is also set to push the demand for breathing circuits.

Dynamics

Rise in the Prevalence of Respiratory Diseases

Increased prevalence of respiratory disease is one the key driver that helps the market to grow during the forecast period. Since rising in respiratory diseases, the need of ventilation is required according to the disease range indeed usage of breathing circuits is needed which indeed will increase the market growth.

For instance, according to the Centres for Disease Control and Prevention COPD affects an estimated 200 Billion people, with 3.2 Billion dying each year, making it the third-leading cause of mortality globally.

Asthma is one of the most common noncommunicable illnesses, impacting 262 Billion people worldwide. With almost 2.2 Billion new instances of lung cancer expected in 2022 and 1.80 Billion fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 Billion fatalities each year, primarily in low and middle-income countries (LMICs). COVID-19 has significantly increased pneumonia fatalities worldwide.

Technological Advancements in Breathing Circuits

Technological advancements in breathing circuits are one of the key factors that help the market to grow during the forecast period. Several advancements have happened in anaesthesia care recently, like Direct Injection of Volatile Anesthetics, Anesthetic Agent Conserving devices, Infrared Low-Cost analyzers, and Closed-Circuit Anesthesia.

Closed-circuit systems have become the newest improvement to anaesthesia delivery systems. These systems function by matching both the oxygen and anaesthetic agent consumption of the patient, as opposed to previous methods of having a constant low fresh gas flow and scavenging system for wasted gas.

Rise in the Prevalence of Obstructive Sleep Apnea

The rise in the prevalence of obstructive sleep apnea is the driver that helps the market to accelerate during the forecast period. For instance, according to the American Sleep apnea Association Sleep apnea is prevalent in as many as 18 Billion Americans alone. This statistic denotes that approximately 1 in every 15 Americans, or 6.62% of the total American population have a case of sleep apnea. Research conducted at the University of California's San Diego campus studied 54 African Americans and 346 Caucasians for the presence of sleep apnea.

The results showed that a full 17 per cent of African American test subjects had a case of obstructive sleep apnea present, compared to 8 per cent of the Caucasian subjects. This denotes a hypothesis that African Americans stand an increased risk of obstructive sleep apnea. Two to four per cent of all Americans have an undiagnosed case of sleep apnea. This accounts for approximately 1 in 50 individuals being undiagnosed.

Increase Demand for Breathing Circuits in ICU

Increase demand for breathing circuits in ICUs is one of the key factors that helps the market to grow during the forecast period. Breathing circuits are used in intensive care units to assist patients with their respiratory processes. These circuits are connected to mechanical ventilators, which are used to supply oxygen to the patient and remove carbon dioxide. The breathing circuit's objective is to provide the patient with a regulated and secure gas flow while preventing infection by collecting any exhaled air or moisture before it reaches the ventilator. Hence The breathing circuit allows oxygen-rich air to be delivered to the patient's lungs while also removing carbon dioxide.

Product Recall

Product recall is one of the factors that hamper the market growth during the forecast period. For instance, in May 2023 Draeger Medical recalled the Seattle PAP Plus as well as VentStar and other breathing circuit/anaesthesia kits after finding that glued connections may loosen before or during ventilation due to a manufacturing error. Partial or complete detachment of components including the water trap, y-piece, or hose connector, may occur as a result.

Loosening or detachment of these parts can interrupt the breathing circuit and may cause severe injury including lack of oxygen (hypoxia) or death. The risk of injury or death is especially great for critically ill patients including newborns (neonates). Thus the above factor will restrict the market from growing during the forecast period.

Also, while the use of breathing circuits in hospitals, clinics, ambulatory surgery centres and home care settings continues to expand, several issues are expected to restrain the expansion of the market globally. Patients may experience breathing difficulty due to unidirectional valves and increasing absorption of carbon dioxide.

Segment Analysis

The global breathing circuits market is segmented based on product type, application, end user and region.

The Hospitals Segment From The End User Segment Accounted for Approximately 43.1% of the Breathing Circuits Share

The hospitals segment from the end user segment accounted for 43.1% and it is expected to be dominated during the forecast period. Hospitals are anticipated to increasingly install breathing circuits owing to a rising number of agreements with several distributors, including local and regional firms. Moreover, the presence of advanced tertiary care settings in many countries is set to aid growth. Hospitals nowadays are also striving to provide comprehensive care to patients to push the adoption of breathing circuits globally, which would drive the segment.

For instance, in December 2022, ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the BiWaze Clear System. This new airway clearance system helps patients clear their airways as well as prevent or treat atelectasis by using Oscillating Lung Expansion (OLE) therapy. BiWaze® Clear can be used to treat both acute and chronic respiratory conditions in the hospital, long-term care and home environments.

Geographical Penetration

North America Accounted for Approximately 37.9% of the Market Share

North America is estimated to hold about 37.9% of the total market share throughout the forecast period, owing to the significant presence of major market players, flourishing healthcare facilities and increasing hospitalization rates for patients with respiratory diseases.

For instance, in October 2022 Medtronic plc a global leader in healthcare technology stated that company separated its combined patient monitoring and respiratory interventions businesses ("NewCo"), which are part of the company's Medical Surgical Portfolio previously. The Respiratory Interventions technology portfolio includes Puritan Bennett ventilators, Shiley airway portfolio, McGrath MAC video laryngoscopy, DAR breathing systems, as well as PAV+, NIV+ and IE Sync ventilation software solutions designed to improve workflow and care delivery.

Furthermore, in October 2021, ARMSTRONG MEDICAL launched Aqua VENT VT heated ventilator breathing circuits. These breathing circuits are used in critical care settings for mechanical life support ventilation and have been engineered to maintain humidity within the breathing circuits in a simple manner.

Competitive Landscape

The major global players in the market include: Medtronic plc, Ambu A/S, Flexicare Medical Ltd, Fisher & Paykel Healthcare Ltd, Dragerwerk AG & Co, Hamilton Medical, Armstrong Medical Industries Inc, Meditera, GE Healthcare, Bio-Med Devices and among others.

COVID-19 Impact Analysis

The COVID-19 epidemic has impacted the economies of diverse countries throughout the world in three ways: directly influencing output and demand; disrupting distribution systems; and having a financial impact on corporations and financial markets. Several nations, including Thailand, Indonesia, and Singapore, are experiencing transportation and distribution issues for healthcare items.

During the COVID-19 pandemic, there was an upsurge in demand for ventilators due to their usage in COVID-19 treatment, however, there was a scarcity of ventilators. For instance, on August 26, 2022, the United States Food and Drug Administration (FDA) issued an update about a medical equipment shortage caused by the COVID-19 pandemic. The device shortage list included categories such as dialysis-related items, personal protective equipment, testing supplies and equipment, and ventilation-related products.

By Product

Open Breathing Circuits
Semi Open Breathing Circuits
Semi-closed breathing systems
Closed Breathing Circuits

By Application

Anaesthesia
Respiratory Dysfunction
Others

By End user

Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

South America
- Brazil
- Argentina
- Rest of South America

Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific

Middle East and Africa

Key Developments

In November 2022, Xplore Health Technologies launched 'Airofit Pro' the world's first smart respiratory device which cost Rs. 34,990. The newly launched 'Airofit Pro' is a respiratory muscle training device.
In August 2022, Dragerwerk AG & Co. KGaA launched the Drager BG ProAir, a closed-circuit breathing device including innovative features to safeguard firemen participating in long-duration deployments, such as those in complex structures, tall buildings, tunnels, and basements.
In January 2022, Armstrong Medical launched its state-of-the-art heated breathing circuit technology, 'AquaVENT VT', in the Middle Eastern market. Armstrong Medical's state-of-the-art AquaVENT VT ventilator circuits manage humidity throughout the entire ventilator breathing circuit, meaning healthcare providers can focus their time on caring for their patients.

DMI Opinion

Overall, the global breathing circuit market has significant growth in future due to many factors Demand for breathing circuits will remain robust, offsetting any industry margin compression. Several key players are expanding their manufacturing facilities across the globe owing to a favourable regulatory environment and an ever, increasing population suffering from chronic ailments. The rising incidence of respiratory dysfunctions is also set to push the demand for breathing circuits. Hence also in the future upcoming innovations in the ventilation system and a rise in research and development will help the breathing circuit market to accelerate in future with utmost advancements.

Why Purchase the Report?

To visualize the global breathing circuits market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global breathing circuits market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global breathing circuits market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Prevalence of Respiratory Diseases
  - 4.1.1.2. Technological Advancements in Breathing Circuits
  - 4.1.1.3. Rise in the Prevalence of Obstructive Sleep Apnea
  - 4.1.1.4. Increase Demand for Breathing Circuits in ICU
- 4.1.2. Restraints
  - 4.1.2.1. Product Recall
- 4.1.3. Opportunity
  - 4.1.3.1. Rise in Research and Developments
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Open Breathing Circuits*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Semi Open Breathing Circuits
7.4. Semi-closed breathing systems
7.5. Closed Breathing Circuits

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Anesthesia*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Respiratory Dysfunction
8.4. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Ambulatory Surgical Centers
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Russia
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Medtronic plc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Ambu A/S
12.3. Flexicare Medical Ltd
12.4. Fisher & Paykel Healthcare Ltd
12.5. Dragerwerk AG & Co.
12.6. Hamilton Medical
12.7. Armstrong Medical Industries Inc
12.8. Meditera
12.9. GE Healthcare
12.10. Bio Med Devices

LIST NOT EXHAUSTIVE